Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 37, Issue 11, 1999, Pages 3528-3532

  Eltringham, I J ^a   Wilson, S M ^a   Drobniewski, F A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM ISOLATE; BACTERIUM ISOLATION; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0032836785     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.11.3528-3532.1999     Document Type: Article

References (22)

1. Bergmann, J. S., and G. L. Woods. 1998. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs. J. Clin. Microbiol. 36:2940-2943.
2. Botha, F. J., F. A. Sirgel, D. P. Parkin, B. W. van de Wal, P. R. Donald, and D. A. Mitchison. 1996. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. S. Afr. Med. J. 86:155-158.
3. Collins, C. H., J. M. Grange, and M. D. Yates. 1997. Tuberculosis bacteriology: organization and practice, p. 98-110. Butterworth Heinemann, Oxford, England.
4. Crowle, A. J. 1986. Studies of antituberculous chemotherapy with an in vitro model of human tuberculosis. Semin. Respir. Infect. 1:262-264.
5. David, H. L., S. Clavel, and F. Clement. 1979. Absorption and growth of the bacteriophage D29 in selected mycobacteria. Ann. Virol. 131:167-184.
6. Drobniewski, F. A. 1997. Is death inevitable with mulliresistant TB plus HIV infection? Lancet 349:71-72.
7. Eltringham, I. J., F. A. Drobniewski, J. A. Mangan, P. D. Butcher, and S. M. Wilson. 1999. Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 37:3524-3527.
8. Gangadharam, P. R., P. F. Pratt, V. K. Perumal, and M. D. Iseman. 1990. The effects of exposure time, drug concentration, and temperature on the activity of ethambutol versus Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 141:1478-1482.
9. Gangadharam, P. R. 1984. Drug resistance in mycobacteria, p. 55-73. CRC Press, Boca Raton, Florida.
10. Heifets, L. B. 1991. Drug susceptibility in the chemotherapy of mycobacterial infections, p. 1-57. CRC Press, Boca Raton, Fla.
11. Jacobs, W. R., Jr., R. G. Barletta, R. Udani, J. Chan, G. Kalkut, G. Sosne, T. Kieser, G. J. Sarkis, G. Hatful, and B. R. Bloom. 1993. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819-822.
12. Narain, J. P., M. C. Raviglione, and A. Kochi. 1992. HIV associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber. Lung Dis. 73:311-321.
13. Pablos-Mendez, A., M. C. Raviglione, and A. Laszlo. 1998. Global surveillance for antituberculous drug resistance, 1994-1997. N. Engl. J. Med. 338: 1641-1649.
14. Raviglione, M. C., D. E. Snider, and A. Kochi. 1995. Global epidemiology of tuberculosis. JAMA 223:220-226.
15. Raviglione, M. C., C. Dye, S. Schmidt, and A. Kochi. 1997. Assessment of worldwide tuberculosis control. Lancet 350:624-629.
16. Riska, P. F., and W. R. Jacobs, Jr. 1998. The use of luciferase-reporter phage for antibiotic-susceptibility testing in mycobacteria. Methods Microbiol. 101: 431-455.
17. Ryan, C., B.-T. Nguyen, and S. J. Sullivan. 1995. Rapid assay for mycobacterial growth and antibiotic susceptibility using gel microdrop encapsulation. J. Clin. Microbiol. 33:1720-1726.
18. Styblo, K. 1991. The impact of HIV infection on the global epidemiology of tuberculosis. Bull. Int. Union Tuberc. Lung Dis. 66:27-32.
19. Tenover, F. C., J. T. Crawford, R. E. Huebner, L. J. Geiter, C. R. Horsburgh, Jr., and R. C. Good. 1993. The resurgence of tuberculosis: is your laboratory ready? J. Clin. Microbiol. 31:767-770.
20. Wenger, P. N., J. Otten, A. Breeden, D. Orfas, C. M. Beck-Sague, and W. R. Jarvis. 1995. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Lancet 345:235-240.
21. Wilson, S. M., Z. Al-Suwaidi, R. McNerney, and F. A. Drobniewski. 1997. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nat. Med. 3:465-468.
22. World Health Organization. 1996. Acquired immunodeficiency syndrome (AIDS)-data as at 30 June 1996. Weekly Epidemiol. Rec. 71:205-206.